Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
EMEmbecta Corp. logo

Embecta Corp. (EMBC)

NASDAQ Global Select · Currency in USD
$6.71 ▼ -0.15 (-2.19%)
At close: Oct 23, 4:00 PM ET. Market closed.
$6.77 ▲ +0.06 (+0.86%)
After hours: Oct 23, 7:57 PM ET

Summary

Previous Close
$6.86
Open
$6.77
Day's Range
$6.69 – $6.88
52 Week Range
$2.77 – $14.91
Volume
717,024
Avg. Volume
1,533,575
Market Cap
$380.19M
Beta (5Y Monthly)
0.83
PE Ratio (TTM)
4.50
EPS (TTM)
$1.50
Earnings Date
Nov 24, 2026
Forward Dividend & Yield
$0.04 (0.60%)
Ex-Dividend Date
Aug 27, 2026
1y Target Est
$5.00

Profile: Embecta Corp.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
1,850
CEO
Devdatt Kurdikar

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition.

Earnings

Next report: Tue, Nov 24, 2026
EPS estimate $0.31 · Revenue est. $267.37M
DateEst.Actual
Aug 7, 2026$0.27$0.56Beat
May 5, 2026$0.42$0.27Miss
Feb 5, 2026$0.67$0.71Beat
Nov 25, 2025$0.70$0.50Miss
Aug 8, 2025$0.46$1.12Beat
May 9, 2025$0.66$0.70Beat

Analyst view

Consensus price target
$5.00 ▼ -25.5%
Range $5.00 – $5.00
Rating: Hold
Buy 0% · Hold 50% · Sell 50%

Get free alerts on EMBC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.